7F5G
The crystal structure of RBD-Nanobody complex, DL4 (SA4)
Summary for 7F5G
Entry DOI | 10.2210/pdb7f5g/pdb |
Descriptor | Spike glycoprotein, Nanobody DL4, alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total) |
Functional Keywords | nanobody, rbd, neutralizing antibody, receptor-binding domain, sars-cov-2, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) More |
Total number of polymer chains | 4 |
Total formula weight | 83332.80 |
Authors | |
Primary citation | Li, T.,Zhou, B.,Li, Y.,Huang, S.,Luo, Z.,Zhou, Y.,Lai, Y.,Gautam, A.,Bourgeau, S.,Wang, S.,Bao, J.,Tan, J.,Lavillette, D.,Li, D. Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2. Int.J.Biol.Macromol., 209:1379-1388, 2022 Cited by PubMed: 35460753DOI: 10.1016/j.ijbiomac.2022.04.096 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.75 Å) |
Structure validation
Download full validation report